Status:

WITHDRAWN

Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery

Lead Sponsor:

Oslo University Hospital

Collaborating Sponsors:

Orexigen Therapeutics, Inc

Conditions:

Obesity

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

Limited/poor weight loss and weight regain are concerns following bariatric surgery, and weight regain may increase the risk for relapse of comorbidities related to obesity. Medications for weight red...

Detailed Description

Study aim and endpoints The aim of this pilot study is to evaluate the effect of Mysimba in patients with suboptimal weight loss or weight regain after bariatric surgery. The primary endpoint is body ...

Eligibility Criteria

Inclusion

  • Men and women aged 18-65 years who have undergone RYGB, mini-RYGB or sleeve gastrectomy 2 or more years previously and either
  • Have a percent total weight loss from time of surgery of \<20% OR
  • Have a regain of at least 5% or more of nadir weight (lowest weight at 12-18 months after surgery) AND
  • Meet current clinical criteria for use of Mysimba (BMI ≥30 kg/m2 or BMI ≥27 kg/m2 with obesity-related comorbidity (diabetes type 2, controlled hypertension, dyslipidemia)

Exclusion

  • Serious illness or complications due to bariatric surgery according to the judgement of the investigators and clinical records
  • Use of any weight loss medications following bariatric surgery
  • Pregnancy or breastfeeding
  • Participation in other weight loss studies
  • Contraindication for use of Mysimba. These include but are not limited to epilepsy or history of seizure, uncontrolled hypertension (blood pressure ≥150/95 mmHg with or without medication), previous or current eating disorder, substance abuse, bipolar depression, serious liver or kidney disease, use of certain medications)

Key Trial Info

Start Date :

November 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04399395

Start Date

November 1 2020

End Date

December 31 2022

Last Update

March 1 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.